Insiders / Lyons Gary a / Activity
Activity — Lyons Gary a
9 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | Sell | TVTX Travere Therapeutics, Inc. Common Stock | $328.6K | -8K -12.21% | 57,500 0.06% of shares | medium |
| Apr 14, 2026 | Exercise | TVTX Travere Therapeutics, Inc. Common Stock | $130.6K | +8K +13.91% | 65,500 0.07% of shares | low |
| May 21, 2026 | Exercise | NBIX Neurocrine Biosciences Inc Common Stock | $0 | +2K +1.38% | 122,141 0.12% of shares | low |
| May 19, 2026 | Grant | TVTX Travere Therapeutics, Inc. Common Stock | $0 | +4K +6.96% | 61,500 0.07% of shares | low |
| May 27, 2026 | Grant | NBIX Neurocrine Biosciences Inc Non-Qualified Stock Option | — | +3K | 2,624 <0.01% of shares | low |
| May 27, 2026 | Grant | NBIX Neurocrine Biosciences Inc Restriced Stock Unit | — | +1K | 1,284 <0.01% of shares | low |
| May 21, 2026 | Exercise | NBIX Neurocrine Biosciences Inc Restricted Stock Unit | — | -2K -100.00% | 0 0.00% of shares | low |
| May 19, 2026 | Grant | TVTX Travere Therapeutics, Inc. Stock option (right to buy) | — | +12K | 12,000 0.01% of shares | low |
| Apr 14, 2026 | Exercise | TVTX Travere Therapeutics, Inc. Stock option (right to buy) | — | +8K | 0 0.00% of shares | low |